By spinning bacteria in a controlled flow, scientists produce aligned cellulose sheets with tensile strength over 500 MPa.

Chemical Dependency Julie Lebouitz, Clinical Social Work/Therapist, Bethlehem, PA, 18018, (484) 789-6694, Struggling with addiction can often feel isolating, and recognizing the need for help ...

H.C. Wainwright analysts have increased their price target for Instil Bio shares to $125, citing the promising Phase 1/2 dose escalation data for AXN-2510, a treatment for non-small cell lung cancer.

Brian Riley as President and Chief Technical Officer, Joanne Lager, MD as Chief Medical Officer, and Adrian Chaisson as Chief of Staff.

By removing such B cells, CAR-T therapy can stop disease progression or help reset the immune system. Though the therapy is approved only for cancer, research suggests that it could also help ...

Instil Bio Inc. (NASDAQ:TIL) saw its stock jump 10% after the company announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for AXN ...

A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. | The Fierce Biotech Fundraising Tracker records ...

The U.S. FDA has cleared Rocket Pharmaceuticals Inc.’s IND application for RP-A701, an AAVrh.74-based gene therapy candidate for the treatment of BAG3-associated dilated cardiomyopathy (BAG3-DCM), a ...